NeuroTrace:A Deep Learning Framework for Monitoring Multiple Sclerosis Progression from Oculomotor and Speech Biomarkers
CSEF · 2026 Medicine & Physiology (Track 2) (Senior Division)
Overview
Multiple Sclerosis (MS) is a chronic autoimmune neurological disorder affecting 2.9 million people worldwide. For MS, an incurable disease, the prevention of progression (from RRMS to PPMS) is crucial to preserve the quality of life. Patients with MS are subject to different disease courses and require individualized treatment; clinicians need to respond quickly to changes in therapy plans and adjust them accordingly. Current monitoring tools include clinical assessments, such as the Expanded Disability Status Scale (EDSS) and MRI scans, which are expensive, time-consuming, and poorly suited to capturing daily neurological changes. This project introduces NeuroTrace, a multimodal AI framework for monitoring MS progression through two digital biomarkers: speech and eye movements. For both modalities, NeuroTrace first classifies the disorder type, then tracks its severity over time. For the audio pipeline, waveforms from the TORGO and UA-Speech datasets (29,313 samples from 43 speakers) were converted into mel-spectrograms and analyzed using a SmallCNN + BiGRU model with leave-one-speaker-out cross-validation. This binary dysarthria classifier achieved an accuracy of 90.4% and an 89.8% weighted F1 score. A Ridge Regression model predicted speech intelligibility with a 12.7% mean absolute error and a Spearman correlation of 0.887, providing a method for tracking the worsening or improvement of one’s dysarthria. For the vision pipeline, 840 clinical eye exam videos from the University of Utah were segmented using two multimodal LLMs. A DenseNet-121 + BiGRU architecture achieved a Weighted F1 score of 80.9% and accuracy of 80.2%. In parallel, the videos were sent to ConVNG, which returned pupil traces that were used to extract oculomotor features, including fixation dispersion and drift velocity. Together, these results support the feasibility of a low-cost, accessible system for longitudinal monitoring of MS progression.
Competition history
- CSEF 2026
Related projects
JSHS · 2020
Computational Eye-Tracking Biomarker for Improved Neuropsychological Evaluation via Deep Learning
CWSF · 2026
NeuroSight: Bridging Oculomic and Acoustic Features for Multi-Disease Prediction via Deep Learning
AJAS · 2025
Automated Detection of Multiple Sclerosis Using Machine Learning
AJAS · 2019
Low-Cost Biomarker for Eye Pattern Localization in Neurodegenerative Disorders
ISEF · 2025
NeuroSyncNN: A Novel Multimodal Neurodegenerative Disease Diagnostics Framework Leveraging Computer Vision, Image Processing and IoMT Targeting Efficient, Real-Time Automated Brain Mapping and Neural-Signal Decoding
ISEF · 2021
Analyzing Eye-Movement Data to Evaluate Motor Cognition Functionality for Early Detection of Neurological Conditions Using Deep Learning
JSHS · 2024
FFTstack: Integrating Fourier Transform and Residual Learning for Arctic Sea Ice Forecasting
ISEF · 2019
Clinical Approach to Predict Cognitive Disorders in Multiple Sclerosis: The Use of Biomarkers Generated by Eye Movement Disorders
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects